- Global Pharma News & Resources

Welsh Minister of Economy opens CatSci’s New Material Science Laboratory

Welsh Minister of Economy opens CatSci’s New Material Science Laboratory

Cardiff, UK – 20/09/2021 – CatSci Ltd, a scientifically-led, commercially-minded and award-winning innovation partner for medicines development was proud to host Vaughan Gething MS, Welsh Minister of Economy, at its facility in Cardiff to open a new material science laboratory. A key milestone of the company’s ambitious £3m investment plan, this new laboratory will further cement the UK’s position as a centre for excellence in pharmaceutical research and development and help increase the UK’s scientific international trade.

As well as opening the new laboratory Mr. Gething toured CatSci’s world-class facilities and discussed with staff CatSci’s impressive contribution to the growing Welsh STEM sector and its significant impact on expediting the delivery of life-changing medicines to patients worldwide.

Economy Minister, Vaughan Gething, said: “The Welsh Government is committed to working with companies across Wales to help them create new jobs in the industries of the future, and I’m very pleased we have been able to work with CatSci as they expand operations in Wales.

Exports of goods and services already contribute a significant amount to our economy. It is vital that we are able to maintain, and grow, this contribution in order to meet the challenges we face both now and in the future. That’s why we’re determined to improve Wales’ export performance even further, despite the challenges in the global trading environment in recent times.”

Dr Ross Burn, CEO at CatSci, said: “We are delighted to welcome the Welsh Minister of Economy to open our new state-of-the-art material science laboratory and see first-hand the excellent work that is being delivered by our talented team here in Cardiff consolidating Wales’ position as the place to go for best-in-class pharmaceutical research and development services.”

Dr Robert Dennehy, Director of Crystallisation and Solid State at CatSci, added: “It is an exciting time to be expanding our material science capabilities offering a holistic approach to particle science and pre-formulation development. I was delighted to show the Minister our state-of-the-art facilities and discuss the positive effect our work has on the development of new therapeutics and Wales’ growing life science sector.”

Dr Jenny Wallis, Business Development Manager at CatSci, said: “We have seen great success in exporting and this has been central to our business growth. With the new facilities we are looking to continue innovating, build on our recent success and further grow our international trade.

Welsh Government support has helped us with our export activities, including market exploration and trade exhibitions as well as general advice from knowledgeable and experienced people. Any Welsh business looking to export or to export more, I would encourage them to speak to the Welsh Government’s export team.”

This year, CatSci is celebrating 10 years of Innovation. To mark this incredible milestone, CatSci is hosting a three-day online symposium entitled: The Next Decade of Drug Development. This free event will take place 5-7 October and includes a fantastic line-up of speakers from AstraZeneca, Bristol Myers Squibb, DeepMatter, Infinity Pharmaceuticals, Merck, R.I., Roche, Novartis, Syngenta and more. Find the full programme and register at:


For more information, including media enquiries, please contact:

CatSci Ltd

Dr. Sofia C. Papadouli
Tel: +44 29 2083 7444

About CatSci

CatSci Ltd is an award-winning innovation partner for medicines development, dedicated to developing economically and environmentally sustainable pharmaceutical manufacturing processes. We proudly serve customers across the globe, meeting their needs from candidate selection to product launch and beyond. Our tailored services include route scouting and selection, initial scale-up and risk management for early development. For later development, we provide process design, assessment and optimisation, scale-up for clinical and commercial manufacture, tech transfer and post-approval improvements. We possess a range of critical enabling technologies including catalysis, material science and analytical development.

Agile, commercially-minded and scientifically-led, CatSci leverages its highly qualified technical team and state-of-the-art facilities to empower our customers to create affordable, best-in-class small molecule therapeutics in a safer, greener and more cost-effective way. Together, we can meet the evolving healthcare needs of the world.

CatSci works efficiently with your preferred partners, while continually strengthening our own industry-leading partnerships across the pharmaceutical supply chain, to address your dynamic drug substance development needs. A true extension of your team, we are a dependable, trusted partner for innovation that takes the time to understand your project objectives and provide you with perfect-for-purpose solutions.

Recognition includes wins at the prestigious CPhI Pharma Awards (Excellence in Pharma: Contract Services and Outsourcing), at the highly esteemed Cardiff Business Awards (International Business of the Year) and the Wales STEM 2020 Awards (STEM scale-up of the year). We were also recently shortlisted for the International Expansion Entrepreneur of the Year at the Barclays Entrepreneur Awards 2020 and the 2020 Bionow Export Award.

Follow us on Twitter and LinkedIn

Editor Details

Last Updated: 24-Sep-2021